---
schema_version: "secwatch.filing_event.v1"
accession: "0001093557-22-000142"
form_type: "8-K"
ticker: "DXCM"
cik: "0001093557"
company_name: "DEXCOM INC"
filed_at: "2022-07-28T23:59:59+00:00"
generated_at: "2026-06-24T07:16:42.793149+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Dexcom Q2 revenue $696.2M (+17% YoY); GAAP EPS $0.12, Non-GAAP EPS $0.17

## Summary
- Revenue $696.2M, +17% reported, +16% organic; U.S. +11%, international +39% reported (+34% organic).
- GAAP operating margin 11.1% (down 590bps); Non-GAAP operating margin 14.6% (down 250bps).
- GAAP net income $50.9M ($0.12 diluted EPS); Non-GAAP net income $69.5M ($0.17 diluted EPS).
- FY2022 guidance: revenue $2.86-2.91B (17-19% growth); Non-GAAP gross margin ~65%, op margin ~16%, Adj. EBITDA ~25%.
- Launched Dexcom ONE in UK/Spain; received CE Mark for G7 sensor algorithm; launched Spanish-language G6 app.

## SEC filing metadata
- accession: 0001093557-22-000142
- form_type: 8-K
- ticker: DXCM
- cik: 0001093557
- company_name: DEXCOM INC
- filed_at: 2022-07-28T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1093557/000109355722000142/0001093557-22-000142-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1093557/000109355722000142/dxcm-20220728.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001093557-22-000142
- JSON: https://secwatch.observer/filing/0001093557-22-000142.json
- Plain text: https://secwatch.observer/filing/0001093557-22-000142.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.